Clinical Trials Browser

Phase 2 × NIH × Camurati-Engelmann Syndrome × Clear all

NCT04501094 2022-03-22

A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma

Phase 2 Terminated

2 enrolled 13 charts

Camurati-Engelmann Syndrome